Evidence map›Paper›PMID 42764334›Full record

ArticleNature communications2026

Retroviruses use different IP

J Ole Klarhof, Donna L Mallery, James C V Stacey, Davide Torre, Michaela Rumlova, Tomas Ruml, John A G Briggs, Leo C James

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

J Ole KlarhofMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0009-0009-8140-8131
Donna L Mallery *MRC Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0003-2713-5215
James C V Stacey *Department of Cell and Virus Structure, Max Planck Institute of Biochemistry, Martinsried, Germany.
Davide TorreDepartment of Cell and Virus Structure, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID http://orcid.org/0000-0002-7072-0578
Michaela RumlovaDepartment of Biotechnology, University of Chemistry and Technology, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-5645-8227
Tomas RumlDepartment of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-5698-4366
John A G BriggsDepartment of Cell and Virus Structure, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID http://orcid.org/0000-0003-3990-6910
Leo C JamesMRC Laboratory of Molecular Biology, Cambridge, UK. lcj@mrc-lmb.cam.ac.uk.ORCID http://orcid.org/0000-0003-2131-0334

Funding

RCUK | Medical Research Council (MRC) U105181010Wellcome TrustWellcome Trust (Wellcome) 200594/Z/16/ZWellcome Trust (Wellcome) 214344/A/18/Z
6 · The paper itself

Abstract

HIV-1 uses the metabolite inositol hexakisphosphate (IP

Indexed as

CapsidMason-Pfizer monkey virusPhytic AcidRetroviridaeAnimalsBinding SitesCapsid ProteinsCryoelectron MicroscopyHIV-1HumansLeukemia Virus, MurineLysineProtein BindingVirus AssemblyCapsid ProteinsLysinePhytic Acid

Identifiers

PMID42764334
PMCPMC13590620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.